Literature DB >> 11154140

Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities.

I Bolibar1, A von Eckardstein, G Assmann, S Thompson.   

Abstract

We studied the role of various markers of lipid metabolism, hemostasis and inflammation in a two year follow-up of 3,000 patients with angina pectoris, during which time 106 patients experienced myocardial infarction or sudden coronary death. Low levels of high density lipoprotein (HDL) cholesterol and of apolipoprotein (apo) A-I were most strongly associated with increased coronary risk. The relative risk per standard deviation increase was 0.68 for HDL cholesterol (95% confidence interval 0.55 to 0.84) and 0.66 for apoA-I (0.54 to 0.81). These associations were independent of other coronary risk factors, other lipid measurements, hemostatic factors, and C-reactive protein (CRP). The associations of total and LDL cholesterol, triglycerides, apoB, and lipoprotein(a) with coronary events were not independent of HDL cholesterol or hemostatic factors. We conclude that HDL cholesterol or apoA-I, hemostatic risk factors, and CRP are important prognostic markers of coronary events in secondary prevention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154140

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

Review 1.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 2.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 4.  Apolipoprotein A-I and risk for cardiovascular diseases.

Authors:  Natalie Khuseyinova; Wolfgang Koenig
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

5.  Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy.

Authors:  Stephen J Nicholls; W H Wilson Tang; Heather Scoffone; Danielle M Brennan; Jaana Hartiala; Hooman Allayee; Stanley L Hazen
Journal:  J Lipid Res       Date:  2010-07-02       Impact factor: 5.922

Review 6.  Dysfunctional high-density lipoprotein.

Authors:  Hong Feng; Xiang-An Li
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

Review 7.  Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.

Authors:  Giuseppe D Norata; Alberico L Catapano
Journal:  Vasc Health Risk Manag       Date:  2005

8.  Detection of pleiotropy through a Phenome-wide association study (PheWAS) of epidemiologic data as part of the Environmental Architecture for Genes Linked to Environment (EAGLE) study.

Authors:  Molly A Hall; Anurag Verma; Kristin D Brown-Gentry; Robert Goodloe; Jonathan Boston; Sarah Wilson; Bob McClellan; Cara Sutcliffe; Holly H Dilks; Nila B Gillani; Hailing Jin; Ping Mayo; Melissa Allen; Nathalie Schnetz-Boutaud; Dana C Crawford; Marylyn D Ritchie; Sarah A Pendergrass
Journal:  PLoS Genet       Date:  2014-12-04       Impact factor: 5.917

9.  High-density lipoprotein ameliorates palmitic acid-induced lipotoxicity and oxidative dysfunction in H9c2 cardiomyoblast cells via ROS suppression.

Authors:  Wei-Wen Kuo; Chih-Yang Huang; Kuen-Ming Wu; Yuan-Man Hsu; Mei-Chin Ying; Fuu-Jen Tsai; Chang-Hai Tsai; Jing-Gung Chung; Jai-Sing Yang; Chih-Hsin Tang; Li-Yi Cheng; Po-Hua Su; Vijaya Padma Viswanadha
Journal:  Nutr Metab (Lond)       Date:  2019-05-28       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.